Objectives To identify serious infection (SI) risk by aetiology and site in patients with
rheumatoid arthritis (RA) compared with those with non-inflammatory rheumatic and …

Th1/Th17-type T-cell responses are upregulated in Behcet’s disease (BD). However,
signaling pathways associated with this aberrant immune response are not clarified. Whole-…

Objective To examine the fracture risk with use of disease-modifying antirheumatic drugs (DMARDs),
statins, proton pump inhibitors (PPIs), opioids, non-opioid analgesics and …

Objective To investigate the rate of incident diabetes mellitus (DM) in patients with rheumatoid
arthritis (RA) and the impact of disease-modifying antirheumatic drug (DMARD) and statin …

Objective To examine the comparative effects of biologic disease-modifying antirheumatic
drugs (bDMARD) and tofacitinib against conventional synthetic DMARD (csDMARD) on …

Objective The objective of this study is to examine the risk of serious infections ( SI s)
associated with biological disease‐modifying antirheumatic drugs ( bDMARD s) compared with …

Objectives Fatigue is a common symptom of chronic inflammatory diseases. The objective
of this study was to investigate fatigue in patients with Behçet's syndrome ( BS ) and to …

Background To assess the risks of malignancies, infections and autoimmune diseases in
patients with rheumatoid arthritis (RA) treated with abatacept compared with other biologic (b) …

Objective. To assess bladder toxicity of cyclophosphamide (CYC) and uroprotective effect of
mesna in rheumatic diseases. Methods. Data of 1018 patients (725 women/293 men) …

Objectives: Interleukin-17 (IL-17) has been associated with the pathogenesis of various
autoimmune/inflammatory diseases. The aim of this study was to investigate the expression of …